182. A patient with Type 2 Diabetes Mellitus is prescribed an SGLT2 inhibitor (e.g., empagliflozin). From a medicinal perspective, what is the technical pathophysiological mechanism of SGLT2 inhibitors?
A.
Increases insulin secretion.
B.
Inhibits sodium-glucose co-transporter 2 in the renal tubules, leading to increased glucose excretion in the urine.
✓
C.
Decreases hepatic glucose production.
D.
Increases insulin sensitivity.
📖 Additional Information
Increases insulin secretion.
Inhibits sodium-glucose co-transporter 2 in the renal tubules, leading to increased glucose excretion in the urine.
